An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B
Clinical trial NCT00124241 · COMPLETED
Trial details
- NCT number
- NCT00124241
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2003-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.